NRX Pharmaceuticals Inc (NRXP)
3.51
-0.01
(-0.28%)
USD |
NASDAQ |
May 17, 16:00
3.51
0.00 (0.00%)
After-Hours: 20:00
NRX Pharmaceuticals Shareholders Equity (Quarterly): -15.07M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -15.07M |
December 31, 2023 | -11.73M |
September 30, 2023 | -6.217M |
June 30, 2023 | -2.808M |
March 31, 2023 | -0.284M |
December 31, 2022 | 7.409M |
September 30, 2022 | 16.78M |
Date | Value |
---|---|
June 30, 2022 | 25.35M |
March 31, 2022 | 31.69M |
December 31, 2021 | 20.81M |
September 30, 2021 | 8.967M |
June 30, 2021 | -17.44M |
December 31, 2020 | -43.77M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-43.77M
Minimum
Dec 2020
31.69M
Maximum
Mar 2022
1.053M
Average
-0.284M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Cyclacel Pharmaceuticals Inc | 0.607M |
Achieve Life Sciences Inc | 49.46M |
EyePoint Pharmaceuticals Inc | 249.93M |
Nanoviricides Inc | 10.65M |
GlycoMimetics Inc | 28.91M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.788M |
Total Liabilities (Quarterly) | 18.86M |